Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase type II, is a transmembrane protein encoded by the gene FOLH1, firstly discovered in prostate cancer cells in 1987 [19,20]. This evidence concerns the gene FOLH1 and prostate carcinoma.